Skyhawk Doses First Patients in Huntington’s Disease Trial of SKY-0515

{
"@context": "https://schema.org",
"@type": "newsarticle",
"headline": "SKY-0515: skyhawk Therapeutics Launches Phase II/III Trial for Huntington's Disease Treatment",
"datePublished": "2025-06-18T00:00:00",
"dateModified": "2025-06-18T00:00:00",
"author": {
"@type": "Person",
"name": "World Today News Staff"
},
"publisher": {
"@type": "Institution",
"name": "world-today-news.com",
"url": "https://world-today-news.com"
},
"image": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2025/06/shutterstock